Neonious Biotech

Neonious Biotech

Created using Figma
Neonious Biotech is introducing the Neonious Token (MDSIM) which is intended to
incentivize large numbers of people to form the Neonious Network, a group of
computers which will perform the molecular dynamics simulations, by distributing
newly generated MDSIMs among these people based on the computing power they
provide to the cause. With the molecular dynamics simulations, Neonious Biotech
will power Alzheimer and dementia research.
Pre-ICO
2021年5月25日
2021年10月31日
100% 完成
募集资金 - 无数据
目标 250 000.00 USD
30 000 000.00 USD
past
  • 1 MDSIM
    =
    0.1 USD
令牌详细信息
断续器
MDSIM
总供应量
125000000
令牌分发
80% Token Sale
11% Token Sale Marketing
6% Scientific Advisors
3% Neonious Employees
接受的货币
ETH, USDC
最小的贡献
250000
USD
公司详情
注册公司名称
Neonious Biotech
注册国家
Germany
奖金结构
The price per token starts at 0.10 USD and will, as a minimum, increase by 0.01 USD after every 250,000 ordered tokens, making it worthwhile to buy early.
额外细节
MVP /原型
平台
Ethereum
受限制的国家
Cuba, Iran, Lebanon, Libya, Syria, Sudan, Yemen
分类
平台

关于 Neonious Biotech

We are pioneers of in silico prediction of drug safety and adverse reactions, limiting cost risks and reducing harm done to animals and humans.

To have the best tools for our drug analysis, we constantly optimize algorithms and pipelines and grow our distributed network which is a cost-efficient source for the needed computing power.

Our research is powered by the Neonious Network
and the Neonious Token (MDSIM).

Neonious is contracted to help to assess a drug for safety and adverse reactions.

Besides manual analysis, Neonious' research team utilizes computational pipelines

These pipelines queue simulations (docking + MD) to be run by the Neonious Network, paid with MDSIMs.

Sombody running the Neonious software, thus being part of the Neonious Network, runs the simulations.

This person is rewarded with easy transferable MDSIMs, which he or her can exchange for real money.

We believe it is beneficial to reduce risks by contract us to analyse your drug, preferable before starting preclinical research, latest before phase 2 of the human trials.

For lower cost, we can utilize the Neonious Network. Alternatively, the calculations can also be done on more private computing resources

技术信息

https://github.com/neonious/WelcomeToCodeRepository

%name%Roadmap

  • 25/05/2021

  • Neonious Tokens can be ordered at the Neonious Biotech website. The earlier they are
    ordered, the cheaper the tokens are.
  • 01/07/2021

  • Extensively tested Neonious MD software available on GitHub (source code) and for
    download (Windows, macOS and Linux). May be used on testing network to generate new
    testing tokens.
  • 01/09/2021

  • Neonious MD software and mining contract passed security audit, results are published.
    Neonious Biotech starts the full ICO, preferably with a major exchange.
  • 31/10/2021

  • Neonious Token sale ends. Neonious Biotech will enable trading of Neonious Tokens for
    anyone on Uniswap by setting up an adequate liquidity pool.
  • 阅读更多
  • 01/11/2021

  • Neonious Biotech will start helping people set up their systems with the Neonious MD
    software to scale the Neonious Network.
  • 01/01/2022

  • Start of actual molecular dynamic simulations targeting dementia.
  • Early 2022

  • We plan to have reached an agreement for the Neonious Token to be listed at a major
    exchange.

Neonious Biotech 球队

验证 0%

注意。未经证实的成员实际上可能不是团队成员

Thomas Rogg
Chief Executive Officer & Head of Development Team
未验证
Elena Elgina
Head of PR & Marketing
未验证
Maria Cristina Fadgy...
Head of Scientific Affairs
未验证
Martin Kämpf
Head of Digital Assets
未验证

Neonious Biotech 最新消息

  • 由于信息更新可能存在时间差异,因此应通过其官方网站或其他沟通渠道验证有关每个ICO项目的准确信息。
  • 这些信息不是投资ICO资金的建议或建议。请自行彻底调查相关信息并决定ICO的参与情况。
  • 如果您认为有任何问题需要纠正,或者您想提交自己的ICO项目,请给我们发送电子邮件。
请阅读免责声明和风险警告。 显示免责声明和风险警告。